Prostate Cancer, Version 3.2024 Featured Updates to the NCCN Guidelines

Edward M. Schaeffer; Sandy Srinivas; Nabil Adra; Yi An; Rhonda Bitting; Brian Chapin; Heather H. Cheng; Anthony Victor D’Amico; Neil Desai; Tanya Dorff; James A. Eastham; Thomas A. Farrington; Xin Gao; Shilpa Gupta; Thomas Guzzo; Joseph E. Ippolito; R. Jeffrey Karnes; Michael R. Kuettel; Joshua M. Lang; Tamara Lotan; Rana R. McKay; Todd Morgan; Julio M. Pow-Sang; Robert Reiter; Mack Roach; Tyler Robin; Stan Rosenfeld; Ahmad Shabsigh; Daniel Spratt; Russell Szmulewitz; Benjamin A. Teply; Jonathan Tward; Richard Valicenti; Jessica Karen Wong; Jenna Snedeker; Deborah A. Freedman-Cass

doi:10.6004/jnccn.2024.0019

Prostate Cancer, Version 3.2024 Featured Updates to the NCCN Guidelines

Edward M. Schaeffer, Sandy Srinivas, Nabil Adra, Yi An, Rhonda Bitting, Brian Chapin, Heather H. Cheng, Anthony Victor D’Amico, Neil Desai, Tanya Dorff, James A. Eastham, Thomas A. Farrington, Xin Gao, Shilpa Gupta, Thomas Guzzo, Joseph E. Ippolito, R. Jeffrey Karnes, Michael R. Kuettel, Joshua M. Lang, Tamara LotanRana R. McKay, Todd Morgan, Julio M. Pow-Sang, Robert Reiter, Mack Roach, Tyler Robin, Stan Rosenfeld, Ahmad Shabsigh, Daniel Spratt, Russell Szmulewitz, Benjamin A. Teply, Jonathan Tward, Richard Valicenti, Jessica Karen Wong, Jenna Snedeker, Deborah A. Freedman-Cass

Urology

Research output: Contribution to journal › Article › peer-review

Abstract

The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel's discussions for the 2024 update to the guidelines with regard to initial risk stratification, initial management of very-low-risk disease, and the treatment of nonmetastatic recurrence.

Original language	English (US)
Pages (from-to)	140-150
Number of pages	11
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	22
Issue number	3
DOIs	https://doi.org/10.6004/jnccn.2024.0019
State	Published - Apr 2024

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2024.0019

Cite this

Schaeffer, E. M., Srinivas, S., Adra, N., An, Y., Bitting, R., Chapin, B., Cheng, H. H., D’Amico, A. V., Desai, N., Dorff, T., Eastham, J. A., Farrington, T. A., Gao, X., Gupta, S., Guzzo, T., Ippolito, J. E., Karnes, R. J., Kuettel, M. R., Lang, J. M., ... Freedman-Cass, D. A. (2024). Prostate Cancer, Version 3.2024 Featured Updates to the NCCN Guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 22(3), 140-150. https://doi.org/10.6004/jnccn.2024.0019

Schaeffer, EM, Srinivas, S, Adra, N, An, Y, Bitting, R, Chapin, B, Cheng, HH, D’Amico, AV, Desai, N, Dorff, T, Eastham, JA, Farrington, TA, Gao, X, Gupta, S, Guzzo, T, Ippolito, JE, Karnes, RJ, Kuettel, MR, Lang, JM, Lotan, T, McKay, RR, Morgan, T, Pow-Sang, JM, Reiter, R, Roach, M, Robin, T, Rosenfeld, S, Shabsigh, A, Spratt, D, Szmulewitz, R, Teply, BA, Tward, J, Valicenti, R, Wong, JK, Snedeker, J & Freedman-Cass, DA 2024, 'Prostate Cancer, Version 3.2024 Featured Updates to the NCCN Guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 22, no. 3, pp. 140-150. https://doi.org/10.6004/jnccn.2024.0019

@article{2d84a04caf274deea4b65e805af02cc2,

title = "Prostate Cancer, Version 3.2024 Featured Updates to the NCCN Guidelines",

abstract = "The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel's discussions for the 2024 update to the guidelines with regard to initial risk stratification, initial management of very-low-risk disease, and the treatment of nonmetastatic recurrence.",

author = "Schaeffer, {Edward M.} and Sandy Srinivas and Nabil Adra and Yi An and Rhonda Bitting and Brian Chapin and Cheng, {Heather H.} and D{\textquoteright}Amico, {Anthony Victor} and Neil Desai and Tanya Dorff and Eastham, {James A.} and Farrington, {Thomas A.} and Xin Gao and Shilpa Gupta and Thomas Guzzo and Ippolito, {Joseph E.} and Karnes, {R. Jeffrey} and Kuettel, {Michael R.} and Lang, {Joshua M.} and Tamara Lotan and McKay, {Rana R.} and Todd Morgan and Pow-Sang, {Julio M.} and Robert Reiter and Mack Roach and Tyler Robin and Stan Rosenfeld and Ahmad Shabsigh and Daniel Spratt and Russell Szmulewitz and Teply, {Benjamin A.} and Jonathan Tward and Richard Valicenti and Wong, {Jessica Karen} and Jenna Snedeker and Freedman-Cass, {Deborah A.}",

year = "2024",

month = apr,

doi = "10.6004/jnccn.2024.0019",

language = "English (US)",

volume = "22",

pages = "140--150",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "3",

}

TY - JOUR

T1 - Prostate Cancer, Version 3.2024 Featured Updates to the NCCN Guidelines

AU - Schaeffer, Edward M.

AU - Srinivas, Sandy

AU - Adra, Nabil

AU - An, Yi

AU - Bitting, Rhonda

AU - Chapin, Brian

AU - Cheng, Heather H.

AU - D’Amico, Anthony Victor

AU - Desai, Neil

AU - Dorff, Tanya

AU - Eastham, James A.

AU - Farrington, Thomas A.

AU - Gao, Xin

AU - Gupta, Shilpa

AU - Guzzo, Thomas

AU - Ippolito, Joseph E.

AU - Karnes, R. Jeffrey

AU - Kuettel, Michael R.

AU - Lang, Joshua M.

AU - Lotan, Tamara

AU - McKay, Rana R.

AU - Morgan, Todd

AU - Pow-Sang, Julio M.

AU - Reiter, Robert

AU - Roach, Mack

AU - Robin, Tyler

AU - Rosenfeld, Stan

AU - Shabsigh, Ahmad

AU - Spratt, Daniel

AU - Szmulewitz, Russell

AU - Teply, Benjamin A.

AU - Tward, Jonathan

AU - Valicenti, Richard

AU - Wong, Jessica Karen

AU - Snedeker, Jenna

AU - Freedman-Cass, Deborah A.

PY - 2024/4

Y1 - 2024/4

N2 - The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel's discussions for the 2024 update to the guidelines with regard to initial risk stratification, initial management of very-low-risk disease, and the treatment of nonmetastatic recurrence.

AB - The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel's discussions for the 2024 update to the guidelines with regard to initial risk stratification, initial management of very-low-risk disease, and the treatment of nonmetastatic recurrence.

UR - http://www.scopus.com/inward/record.url?scp=85190902331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85190902331&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2024.0019

DO - 10.6004/jnccn.2024.0019

M3 - Article

C2 - 38626801

AN - SCOPUS:85190902331

SN - 1540-1405

VL - 22

SP - 140

EP - 150

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 3

ER -

Prostate Cancer, Version 3.2024 Featured Updates to the NCCN Guidelines

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this